Drug Discovery Informatics Market Size and Forecast

Market Insights

The global drug discovery informatics market size was estimated at USD 2.32 billion in 2021 and is likely to grow at a CAGR of 9.23% during 2022-2028 to reach USD 4.35 billion in 2028.

Want to know more about the market scope? 

What is drug discovery informatics?

Drug discovery informatics encompasses the creation of systems that can work more capably with large sets of clinical trial and treatment data. Discovery and development of drugs is a highly complex process, requiring creation of large amount data and information.

Key Players

Some of the major players in the drug discovery informatics market are-

• Accenture PLC
• Albany Molecular Research Inc.
• Charles River Laboratories International, Inc.
• Clarivate Analytics LLC
• Eurofins Scientific SE
• IBM Corporation
• Jubilant Life Sciences Limited
• PerkinElmer Inc.
• Schrödinger, Inc.
• Thermo Fisher Scientific Inc.

Market Dynamics

The prime factors that are likely to drive the market are the increasing expenditure in R&D activities, growing support for research in the pharmaceutical areas, especially for rare diseases, and the escalating use of informatics for discovery of new drugs.

Want to have a closer look at this market report? 

Segments Analysis

By Function Type

The market is segmented as sequencing & target data analysis, docking, molecular modelling, library & database preparation, and others. The sequencing & target data analysis segment held the largest share of the market in 2021, owing to the increased application of sequencing analysis and ease of handling information from different sources and domains. The segment is likely to maintain its leading position during the forecast period as well.

By End-User Type

The drug discovery informatics market is segmented as pharmaceutical companies, biotechnology companies, contract research organizations (CROs), and others. The pharmaceutical companies’ segment led the market in 2021 and is expected to dominate the market over the forecast period. The growth of the segment is driven by the extensive use of software for pre-clinical research & developmental activities, target identification, compound screening and lead identification, and streamlining drug discovery processes.

Regional Analysis

North America held the largest share of the market in 2021, followed by Europe. North America is expected to command the market during the forecast period as well. The dominant position of North America is due to the presence of major CROs and increasing expenditure by pharmaceutical and biopharmaceutical companies. On the other hand, Asia-Pacific is likely to grow at the highest CAGR during the forecast period, driven by the rapid growth of pharmaceutical and biopharmaceutical industries and growing number of CROs in the region, with China and India being the major countries offering promising growth opportunities over the forecast period.

Know the high-growth countries in this report. 

Segmentation

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

The drug discovery informatics market is segmented into the following categories:

By Function Type:

• Sequencing & Target Data Analysis
• Docking
• Molecular Modelling
• Library & Database Preparation
• Others

By Application Type:

• Drug Discovery
• Drug Development
  • (Application Type Analysis: Preclinical Testing and Clinical Trials)

By Solution Type:

• Software
• Services

By End-User Type:

• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Others

By Region:

• North America (Country Analysis: the USA, Canada, and Mexico)
• Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
• Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Research Methodology

This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Customization Option

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players)
• SWOT analysis of key players (up to 3 players)

Market Segmentation

• Current market segmentation of any one of the solution types by end-user type.

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.